{

"Afghanistan":{"Title":"Afghanistan","Country Id":"AFG","Adults (ages 15-49) newly infected with HIV":"1300","Adults (ages 15+) and children (0-14 years) living with HIV":"11000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1500","Adults (ages 15+) living with HIV":"10000","Antiretroviral therapy coverage (% of people living with HIV)":"10","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"9","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"6100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"1","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"6.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"1.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"4.9","Estimated antiretroviral therapy coverage among children":"12","Estimated number of children needing antiretroviral therapy based on WHO methods":"500","Estimated number of people (all ages) living with HIV":"11000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"500","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"9","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.07","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.11","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"0.04","Number of deaths due to HIV/AIDS":"500","Number of new HIV infections":"1500","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"24","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"60","Reported number of people receiving antiretroviral therapy":"1044","Women's share of population ages 15+ living with HIV (%)":"29","Young people (ages 15-24) newly infected with HIV":"500"},

"Albania":{"Title":"Albania","Country Id":"ALB","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"1400","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"1400","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.02","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.09","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"23.3","Young people (ages 15-24) newly infected with HIV":"100"},

"Algeria":{"Title":"Algeria","Country Id":"DZA","Adults (ages 15-49) newly infected with HIV":"1900","Adults (ages 15+) and children (0-14 years) living with HIV":"22000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2100","Adults (ages 15+) living with HIV":"21000","Antiretroviral therapy coverage (% of people living with HIV)":"67","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"55","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"2000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.09","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"45.6","Young people (ages 15-24) newly infected with HIV":"500"},

"American Samoa":{"Title":"American Samoa","Country Id":"ASM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Andorra":{"Title":"Andorra","Country Id":"AND","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Angola":{"Title":"Angola","Country Id":"AGO","Adults (ages 15-49) newly infected with HIV":"20000","Adults (ages 15+) and children (0-14 years) living with HIV":"340000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"26000","Adults (ages 15+) living with HIV":"310000","Antiretroviral therapy coverage (% of people living with HIV)":"27","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"63","Children (0-14) living with HIV":"31000","Children (ages 0-14) newly infected with HIV":"4600","Children orphaned by HIV/AIDS":"180000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"32.5","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"31.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"31.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"35.3","Estimated antiretroviral therapy coverage among children":"16","Estimated number of children needing antiretroviral therapy based on WHO methods":"31000","Estimated number of people (all ages) living with HIV":"340000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"24000","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"63","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.52","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"2.25","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.78","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.45","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.99","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.9","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.51","Incidence of HIV, all (per 1,000 uninfected population)":"0.84","New HIV infections (per 1000 uninfected population) Both Sex":"0.84","Number of deaths due to HIV/AIDS":"13000","Number of new HIV infections":"26000","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"15030","Prevalence of HIV, female (% ages 15-24)":"1.2","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.9","Reported number of children receiving antiretroviral therapy":"5113","Reported number of people receiving antiretroviral therapy":"93310","Women's share of population ages 15+ living with HIV (%)":"69.6","Young people (ages 15-24) newly infected with HIV":"9000"},

"Antigua and Barbuda":{"Title":"Antigua and Barbuda","Country Id":"ATG","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Argentina":{"Title":"Argentina","Country Id":"ARG","Adults (ages 15-49) newly infected with HIV":"5400","Adults (ages 15+) and children (0-14 years) living with HIV":"140000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5900","Adults (ages 15+) living with HIV":"130000","Antiretroviral therapy coverage (% of people living with HIV)":"58","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"26000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"140000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.16","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.22","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.24","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.14","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.34","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.13","New HIV infections (per 1000 uninfected population) Both Sex":"0.13","Number of deaths due to HIV/AIDS":"1400","Number of new HIV infections":"5900","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"1794","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"1800","Reported number of people receiving antiretroviral therapy":"90769","Women's share of population ages 15+ living with HIV (%)":"32.3","Young people (ages 15-24) newly infected with HIV":"1100"},

"Armenia":{"Title":"Armenia","Country Id":"ARM","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"3500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"3500","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"20.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"12.5","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.14","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"34.9","Young people (ages 15-24) newly infected with HIV":"100"},

"Aruba":{"Title":"Aruba","Country Id":"ABW","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Australia":{"Title":"Australia","Country Id":"AUS","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"29000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"29000","Antiretroviral therapy coverage (% of people living with HIV)":"83","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"100","Estimated number of children needing antiretroviral therapy based on WHO methods":"100","Estimated number of people (all ages) living with HIV":"29000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"100","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"100","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.02","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.11","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"0.03","Number of deaths due to HIV/AIDS":"100","Number of new HIV infections":"820","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"66","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"15","Reported number of people receiving antiretroviral therapy":"23823","Women's share of population ages 15+ living with HIV (%)":"12.3","Young people (ages 15-24) newly infected with HIV":"100"},

"Austria":{"Title":"Austria","Country Id":"AUT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Azerbaijan":{"Title":"Azerbaijan","Country Id":"AZE","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"9700","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"9600","Antiretroviral therapy coverage (% of people living with HIV)":"52","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"75","Children (0-14) living with HIV":"200","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"3500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"34.1","Young people (ages 15-24) newly infected with HIV":"100"},

"Bahamas, The":{"Title":"Bahamas, The","Country Id":"BHS","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Bahrain":{"Title":"Bahrain","Country Id":"BHR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Bangladesh":{"Title":"Bangladesh","Country Id":"BGD","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Barbados":{"Title":"Barbados","Country Id":"BRB","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"2700","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"2700","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.15","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.19","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.12","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.34","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.27","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.41","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.18","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"42.7","Young people (ages 15-24) newly infected with HIV":"100"},

"Belarus":{"Title":"Belarus","Country Id":"BLR","Adults (ages 15-49) newly infected with HIV":"1700","Adults (ages 15+) and children (0-14 years) living with HIV":"28000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1900","Adults (ages 15+) living with HIV":"28000","Antiretroviral therapy coverage (% of people living with HIV)":"63","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"2400","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.17","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.22","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.12","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.39","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.34","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.45","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.2","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"45.2","Young people (ages 15-24) newly infected with HIV":"200"},

"Belgium":{"Title":"Belgium","Country Id":"BEL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Belize":{"Title":"Belize","Country Id":"BLZ","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"41.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"45","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Benin":{"Title":"Benin","Country Id":"BEN","Adults (ages 15-49) newly infected with HIV":"2800","Adults (ages 15+) and children (0-14 years) living with HIV":"75000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"3500","Adults (ages 15+) living with HIV":"69000","Antiretroviral therapy coverage (% of people living with HIV)":"65","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"5600","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"45000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.47","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.63","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.32","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.52","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.62","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.42","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.17","Incidence of HIV, all (per 1,000 uninfected population)":"0.31","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.4","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61.3","Young people (ages 15-24) newly infected with HIV":"1100"},

"Bermuda":{"Title":"Bermuda","Country Id":"BMU","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Bhutan":{"Title":"Bhutan","Country Id":"BTN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Bolivia":{"Title":"Bolivia","Country Id":"BOL","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"19000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"19000","Antiretroviral therapy coverage (% of people living with HIV)":"60","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"84","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"9200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.06","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.14","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.2","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.08","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30.7","Young people (ages 15-24) newly infected with HIV":"200"},

"Bosnia and Herzegovina":{"Title":"Bosnia and Herzegovina","Country Id":"BIH","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Botswana":{"Title":"Botswana","Country Id":"BWA","Adults (ages 15-49) newly infected with HIV":"8700","Adults (ages 15+) and children (0-14 years) living with HIV":"380000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"9500","Adults (ages 15+) living with HIV":"370000","Antiretroviral therapy coverage (% of people living with HIV)":"82","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"65000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"8.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"11.56","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"4.79","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"8.23","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"9.8","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"6.88","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.66","Incidence of HIV, all (per 1,000 uninfected population)":"4.78","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"9.3","Prevalence of HIV, male (% ages 15-24)":"5","Prevalence of HIV, total (% of population ages 15-49)":"20.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"57.1","Young people (ages 15-24) newly infected with HIV":"3200"},

"Brazil":{"Title":"Brazil","Country Id":"BRA","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"920000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"48000","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"60","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"920000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"0.23","New HIV infections (per 1000 uninfected population) Both Sex":"0.23","Number of deaths due to HIV/AIDS":"14000","Number of new HIV infections":"48000","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"631386","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"British Virgin Islands":{"Title":"British Virgin Islands","Country Id":"VGB","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Brunei Darussalam":{"Title":"Brunei Darussalam","Country Id":"BRN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Bulgaria":{"Title":"Bulgaria","Country Id":"BGR","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"3300","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"3300","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.03","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"20.4","Young people (ages 15-24) newly infected with HIV":"100"},

"Burkina Faso":{"Title":"Burkina Faso","Country Id":"BFA","Adults (ages 15-49) newly infected with HIV":"1700","Adults (ages 15+) and children (0-14 years) living with HIV":"100000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2700","Adults (ages 15+) living with HIV":"92000","Antiretroviral therapy coverage (% of people living with HIV)":"67","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"81","Children (0-14) living with HIV":"9800","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"100000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.2","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.24","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.16","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.2","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.18","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.4","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"0.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"60.6","Young people (ages 15-24) newly infected with HIV":"1000"},

"Burundi":{"Title":"Burundi","Country Id":"BDI","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"85000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1900","Adults (ages 15+) living with HIV":"76000","Antiretroviral therapy coverage (% of people living with HIV)":"84","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"69","Children (0-14) living with HIV":"9400","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"73000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.18","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.25","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.2","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.23","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.18","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.17","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.6","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"60.1","Young people (ages 15-24) newly infected with HIV":"500"},

"Cabo Verde":{"Title":"Cabo Verde","Country Id":"CPV","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"2500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"2400","Antiretroviral therapy coverage (% of people living with HIV)":"62","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.24","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.28","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.2","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.29","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.3","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.29","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.09","Incidence of HIV, all (per 1,000 uninfected population)":"0.19","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.2","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.6","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"53.8","Young people (ages 15-24) newly infected with HIV":"100"},

"Cambodia":{"Title":"Cambodia","Country Id":"KHM","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"73000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"70000","Antiretroviral therapy coverage (% of people living with HIV)":"84","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"89","Children (0-14) living with HIV":"2900","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"53000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.06","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.1","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"52","Young people (ages 15-24) newly infected with HIV":"200"},

"Cameroon":{"Title":"Cameroon","Country Id":"CMR","Adults (ages 15-49) newly infected with HIV":"13000","Adults (ages 15+) and children (0-14 years) living with HIV":"510000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"17000","Adults (ages 15+) living with HIV":"470000","Antiretroviral therapy coverage (% of people living with HIV)":"62","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"73","Children (0-14) living with HIV":"31000","Children (ages 0-14) newly infected with HIV":"3300","Children orphaned by HIV/AIDS":"420000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.09","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.64","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.55","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.44","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.76","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.42","Incidence of HIV, all (per 1,000 uninfected population)":"0.69","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.4","Prevalence of HIV, male (% ages 15-24)":"0.6","Prevalence of HIV, total (% of population ages 15-49)":"3.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"67","Young people (ages 15-24) newly infected with HIV":"5400"},

"Canada":{"Title":"Canada","Country Id":"CAN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Cayman Islands":{"Title":"Cayman Islands","Country Id":"CYM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Central African Republic":{"Title":"Central African Republic","Country Id":"CAF","Adults (ages 15-49) newly infected with HIV":"4100","Adults (ages 15+) and children (0-14 years) living with HIV":"100000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4900","Adults (ages 15+) living with HIV":"96000","Antiretroviral therapy coverage (% of people living with HIV)":"46","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"94","Children (0-14) living with HIV":"6900","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"90000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.68","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"2.16","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.2","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"2","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"2.32","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.68","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.68","Incidence of HIV, all (per 1,000 uninfected population)":"1.1","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.4","Prevalence of HIV, male (% ages 15-24)":"0.9","Prevalence of HIV, total (% of population ages 15-49)":"3.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.8","Young people (ages 15-24) newly infected with HIV":"1700"},

"Chad":{"Title":"Chad","Country Id":"TCD","Adults (ages 15-49) newly infected with HIV":"3400","Adults (ages 15+) and children (0-14 years) living with HIV":"120000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5200","Adults (ages 15+) living with HIV":"110000","Antiretroviral therapy coverage (% of people living with HIV)":"58","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"67","Children (0-14) living with HIV":"14000","Children (ages 0-14) newly infected with HIV":"1500","Children orphaned by HIV/AIDS":"56000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"11.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"15.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"10.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"17.4","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.54","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.71","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.37","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.5","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.59","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.41","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.14","Incidence of HIV, all (per 1,000 uninfected population)":"0.34","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.6","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"60.5","Young people (ages 15-24) newly infected with HIV":"1700"},

"Chile":{"Title":"Chile","Country Id":"CHL","Adults (ages 15-49) newly infected with HIV":"4500","Adults (ages 15+) and children (0-14 years) living with HIV":"74000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5100","Adults (ages 15+) living with HIV":"74000","Antiretroviral therapy coverage (% of people living with HIV)":"68","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"96","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.31","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.15","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.47","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.46","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.74","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.1","Incidence of HIV, all (per 1,000 uninfected population)":"0.27","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"17.7","Young people (ages 15-24) newly infected with HIV":"1000"},

"China":{"Title":"China","Country Id":"CHN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Colombia":{"Title":"Colombia","Country Id":"COL","Adults (ages 15-49) newly infected with HIV":"11000","Adults (ages 15+) and children (0-14 years) living with HIV":"200000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"12000","Adults (ages 15+) living with HIV":"190000","Antiretroviral therapy coverage (% of people living with HIV)":"68","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"59000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"31.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"29","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"38","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"34.8","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.16","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.14","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.18","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.4","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.21","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.59","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.07","Incidence of HIV, all (per 1,000 uninfected population)":"0.25","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"24.9","Young people (ages 15-24) newly infected with HIV":"1400"},

"Comoros":{"Title":"Comoros","Country Id":"COM","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"200","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"200","Antiretroviral therapy coverage (% of people living with HIV)":"82","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.02","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.02","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.01","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"43.1","Young people (ages 15-24) newly infected with HIV":"100"},

"Congo, Dem. Rep.":{"Title":"Congo, Dem. Rep.","Country Id":"COD","Adults (ages 15-49) newly infected with HIV":"14000","Adults (ages 15+) and children (0-14 years) living with HIV":"520000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"23000","Adults (ages 15+) living with HIV":"460000","Antiretroviral therapy coverage (% of people living with HIV)":"53","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"45","Children (0-14) living with HIV":"68000","Children (ages 0-14) newly infected with HIV":"7700","Children orphaned by HIV/AIDS":"440000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.34","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.55","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.14","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.31","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.48","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.15","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.09","Incidence of HIV, all (per 1,000 uninfected population)":"0.22","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.5","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"72.8","Young people (ages 15-24) newly infected with HIV":"6700"},

"Congo, Rep.":{"Title":"Congo, Rep.","Country Id":"COG","Adults (ages 15-49) newly infected with HIV":"6100","Adults (ages 15+) and children (0-14 years) living with HIV":"100000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"8000","Adults (ages 15+) living with HIV":"96000","Antiretroviral therapy coverage (% of people living with HIV)":"25","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"10","Children (0-14) living with HIV":"8000","Children (ages 0-14) newly infected with HIV":"1500","Children orphaned by HIV/AIDS":"67000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"26.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"45.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"2.61","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"4.27","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.98","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"2.5","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"3.47","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.55","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.8","Incidence of HIV, all (per 1,000 uninfected population)":"1.55","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"2.2","Prevalence of HIV, male (% ages 15-24)":"0.6","Prevalence of HIV, total (% of population ages 15-49)":"3.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"68.2","Young people (ages 15-24) newly infected with HIV":"2500"},

"Costa Rica":{"Title":"Costa Rica","Country Id":"CRI","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"14000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"14000","Antiretroviral therapy coverage (% of people living with HIV)":"66","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.14","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.33","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.2","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.46","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.19","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"28.1","Young people (ages 15-24) newly infected with HIV":"200"},

"Cote d'Ivoire":{"Title":"Cote d'Ivoire","Country Id":"CIV","Adults (ages 15-49) newly infected with HIV":"9200","Adults (ages 15+) and children (0-14 years) living with HIV":"430000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"12000","Adults (ages 15+) living with HIV":"400000","Antiretroviral therapy coverage (% of people living with HIV)":"63","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"80","Children (0-14) living with HIV":"32000","Children (ages 0-14) newly infected with HIV":"1900","Children orphaned by HIV/AIDS":"340000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"24","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"32.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.57","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.93","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.2","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.8","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.02","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.59","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.5","Incidence of HIV, all (per 1,000 uninfected population)":"0.51","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.1","Prevalence of HIV, male (% ages 15-24)":"0.6","Prevalence of HIV, total (% of population ages 15-49)":"2.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"65.8","Young people (ages 15-24) newly infected with HIV":"2800"},

"Croatia":{"Title":"Croatia","Country Id":"HRV","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"1600","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"1600","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.02","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":"100"},

"Cuba":{"Title":"Cuba","Country Id":"CUB","Adults (ages 15-49) newly infected with HIV":"1400","Adults (ages 15+) and children (0-14 years) living with HIV":"32000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1700","Adults (ages 15+) living with HIV":"32000","Antiretroviral therapy coverage (% of people living with HIV)":"76","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1700","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.18","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.28","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.26","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.43","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"17.7","Young people (ages 15-24) newly infected with HIV":"500"},

"Curacao":{"Title":"Curacao","Country Id":"CUW","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Cyprus":{"Title":"Cyprus","Country Id":"CYP","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Czech Republic":{"Title":"Czech Republic","Country Id":"CZE","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Denmark":{"Title":"Denmark","Country Id":"DNK","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Djibouti":{"Title":"Djibouti","Country Id":"DJI","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"6800","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"6200","Antiretroviral therapy coverage (% of people living with HIV)":"43","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"35","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"7000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.15","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.1","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.16","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.16","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.15","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.4","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"0.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"56.3","Young people (ages 15-24) newly infected with HIV":"100"},

"Dominica":{"Title":"Dominica","Country Id":"DMA","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Dominican Republic":{"Title":"Dominican Republic","Country Id":"DOM","Adults (ages 15-49) newly infected with HIV":"2500","Adults (ages 15+) and children (0-14 years) living with HIV":"72000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2800","Adults (ages 15+) living with HIV":"71000","Antiretroviral therapy coverage (% of people living with HIV)":"48","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"80","Children (0-14) living with HIV":"1300","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"48000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.48","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.35","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.61","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.45","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.27","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.63","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.1","Incidence of HIV, all (per 1,000 uninfected population)":"0.27","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"0.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"47.6","Young people (ages 15-24) newly infected with HIV":"1000"},

"Ecuador":{"Title":"Ecuador","Country Id":"ECU","Adults (ages 15-49) newly infected with HIV":"2200","Adults (ages 15+) and children (0-14 years) living with HIV":"47000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2400","Adults (ages 15+) living with HIV":"46000","Antiretroviral therapy coverage (% of people living with HIV)":"65","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"88","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"18000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.1","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.24","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.15","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.34","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30.8","Young people (ages 15-24) newly infected with HIV":"500"},

"Egypt, Arab Rep.":{"Title":"Egypt, Arab Rep.","Country Id":"EGY","Adults (ages 15-49) newly infected with HIV":"4500","Adults (ages 15+) and children (0-14 years) living with HIV":"26000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5000","Adults (ages 15+) living with HIV":"25000","Antiretroviral therapy coverage (% of people living with HIV)":"32","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"16","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"4300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"4.1","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"6.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"6.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"9.5","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30","Young people (ages 15-24) newly infected with HIV":"1000"},

"El Salvador":{"Title":"El Salvador","Country Id":"SLV","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"27000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"26000","Antiretroviral therapy coverage (% of people living with HIV)":"50","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"56","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"15000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.23","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.14","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.33","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"37.3","Young people (ages 15-24) newly infected with HIV":"200"},

"Equatorial Guinea":{"Title":"Equatorial Guinea","Country Id":"GNQ","Adults (ages 15-49) newly infected with HIV":"4400","Adults (ages 15+) and children (0-14 years) living with HIV":"65000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5200","Adults (ages 15+) living with HIV":"62000","Antiretroviral therapy coverage (% of people living with HIV)":"35","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"48","Children (0-14) living with HIV":"2800","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"23000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"5.45","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"7.26","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"3.85","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"6.48","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"7.76","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"5.63","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.16","Incidence of HIV, all (per 1,000 uninfected population)":"4.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"3.1","Prevalence of HIV, male (% ages 15-24)":"1.6","Prevalence of HIV, total (% of population ages 15-49)":"7.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"51.5","Young people (ages 15-24) newly infected with HIV":"1200"},

"Eritrea":{"Title":"Eritrea","Country Id":"ERI","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"14000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"13000","Antiretroviral therapy coverage (% of people living with HIV)":"62","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"39","Children (0-14) living with HIV":"1200","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"9600","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.15","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.22","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.07","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.15","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.12","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.11","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.6","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.4","Young people (ages 15-24) newly infected with HIV":"100"},

"Estonia":{"Title":"Estonia","Country Id":"EST","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Eswatini":{"Title":"Eswatini","Country Id":"SWZ","Adults (ages 15-49) newly infected with HIV":"4100","Adults (ages 15+) and children (0-14 years) living with HIV":"200000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4500","Adults (ages 15+) living with HIV":"190000","Antiretroviral therapy coverage (% of people living with HIV)":"96","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"10000","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"43000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"9.19","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"15.38","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"3.95","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"9.77","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"13.97","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"6.29","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.03","Incidence of HIV, all (per 1,000 uninfected population)":"4.9","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"12.3","Prevalence of HIV, male (% ages 15-24)":"4.1","Prevalence of HIV, total (% of population ages 15-49)":"27","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"63.4","Young people (ages 15-24) newly infected with HIV":"2000"},

"Ethiopia":{"Title":"Ethiopia","Country Id":"ETH","Adults (ages 15-49) newly infected with HIV":"11000","Adults (ages 15+) and children (0-14 years) living with HIV":"670000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"15000","Adults (ages 15+) living with HIV":"630000","Antiretroviral therapy coverage (% of people living with HIV)":"74","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"74","Children (0-14) living with HIV":"44000","Children (ages 0-14) newly infected with HIV":"3200","Children orphaned by HIV/AIDS":"310000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"24.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"39.1","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"20.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"38.3","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.22","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.33","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.23","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.29","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.17","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.07","Incidence of HIV, all (per 1,000 uninfected population)":"0.16","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.4","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"0.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"62.7","Young people (ages 15-24) newly infected with HIV":"4500"},

"Faroe Islands":{"Title":"Faroe Islands","Country Id":"FRO","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Fiji":{"Title":"Fiji","Country Id":"FJI","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"1000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"1000","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.08","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.26","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.39","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31.8","Young people (ages 15-24) newly infected with HIV":"100"},

"Finland":{"Title":"Finland","Country Id":"FIN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"France":{"Title":"France","Country Id":"FRA","Adults (ages 15-49) newly infected with HIV":"5400","Adults (ages 15+) and children (0-14 years) living with HIV":"190000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"6400","Adults (ages 15+) living with HIV":"190000","Antiretroviral therapy coverage (% of people living with HIV)":"82","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"2800","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.1","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":"1000"},

"French Polynesia":{"Title":"French Polynesia","Country Id":"PYF","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Gabon":{"Title":"Gabon","Country Id":"GAB","Adults (ages 15-49) newly infected with HIV":"1100","Adults (ages 15+) and children (0-14 years) living with HIV":"51000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1500","Adults (ages 15+) living with HIV":"48000","Antiretroviral therapy coverage (% of people living with HIV)":"51","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"71","Children (0-14) living with HIV":"2800","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"20000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.11","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.87","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.36","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.07","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.54","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.65","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.33","Incidence of HIV, all (per 1,000 uninfected population)":"0.74","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.5","Prevalence of HIV, male (% ages 15-24)":"0.5","Prevalence of HIV, total (% of population ages 15-49)":"3.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"67.6","Young people (ages 15-24) newly infected with HIV":"500"},

"Gambia, The":{"Title":"Gambia, The","Country Id":"GMB","Adults (ages 15-49) newly infected with HIV":"1900","Adults (ages 15+) and children (0-14 years) living with HIV":"28000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2400","Adults (ages 15+) living with HIV":"26000","Antiretroviral therapy coverage (% of people living with HIV)":"29","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"49","Children (0-14) living with HIV":"2100","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"20000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.89","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.32","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.46","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.77","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.99","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.54","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.91","Incidence of HIV, all (per 1,000 uninfected population)":"1.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.6","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"1.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61","Young people (ages 15-24) newly infected with HIV":"500"},

"Georgia":{"Title":"Georgia","Country Id":"GEO","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"9100","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"9000","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31.9","Young people (ages 15-24) newly infected with HIV":""},

"Germany":{"Title":"Germany","Country Id":"DEU","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Ghana":{"Title":"Ghana","Country Id":"GHA","Adults (ages 15-49) newly infected with HIV":"16000","Adults (ages 15+) and children (0-14 years) living with HIV":"340000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"20000","Adults (ages 15+) living with HIV":"320000","Antiretroviral therapy coverage (% of people living with HIV)":"45","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"75","Children (0-14) living with HIV":"26000","Children (ages 0-14) newly infected with HIV":"3000","Children orphaned by HIV/AIDS":"220000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.62","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.42","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.42","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.78","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.38","Incidence of HIV, all (per 1,000 uninfected population)":"0.7","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"1.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"65.6","Young people (ages 15-24) newly infected with HIV":"5600"},

"Greece":{"Title":"Greece","Country Id":"GRC","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Greenland":{"Title":"Greenland","Country Id":"GRL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Grenada":{"Title":"Grenada","Country Id":"GRD","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Guam":{"Title":"Guam","Country Id":"GUM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Guatemala":{"Title":"Guatemala","Country Id":"GTM","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"36000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1100","Adults (ages 15+) living with HIV":"35000","Antiretroviral therapy coverage (% of people living with HIV)":"58","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"53","Children (0-14) living with HIV":"1200","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"23000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"22.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"21.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"26.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"24.2","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.16","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.07","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"40.6","Young people (ages 15-24) newly infected with HIV":"200"},

"Guinea":{"Title":"Guinea","Country Id":"GIN","Adults (ages 15-49) newly infected with HIV":"3900","Adults (ages 15+) and children (0-14 years) living with HIV":"110000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4800","Adults (ages 15+) living with HIV":"100000","Antiretroviral therapy coverage (% of people living with HIV)":"45","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"9000","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"65000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"15.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.72","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.41","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.68","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.85","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.49","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.24","Incidence of HIV, all (per 1,000 uninfected population)":"0.39","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.8","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"67","Young people (ages 15-24) newly infected with HIV":"1900"},

"Guinea-Bissau":{"Title":"Guinea-Bissau","Country Id":"GNB","Adults (ages 15-49) newly infected with HIV":"1600","Adults (ages 15+) and children (0-14 years) living with HIV":"40000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2100","Adults (ages 15+) living with HIV":"37000","Antiretroviral therapy coverage (% of people living with HIV)":"41","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"59","Children (0-14) living with HIV":"3200","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"28000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.53","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.98","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.07","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.85","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"2.14","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.55","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.61","Incidence of HIV, all (per 1,000 uninfected population)":"1.15","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.2","Prevalence of HIV, male (% ages 15-24)":"0.7","Prevalence of HIV, total (% of population ages 15-49)":"3.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"62.8","Young people (ages 15-24) newly infected with HIV":"1000"},

"Guyana":{"Title":"Guyana","Country Id":"GUY","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"8700","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"8300","Antiretroviral therapy coverage (% of people living with HIV)":"69","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.51","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.52","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.49","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.71","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.66","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.76","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.2","Incidence of HIV, all (per 1,000 uninfected population)":"0.42","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"1.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"48.7","Young people (ages 15-24) newly infected with HIV":"100"},

"Haiti":{"Title":"Haiti","Country Id":"HTI","Adults (ages 15-49) newly infected with HIV":"4600","Adults (ages 15+) and children (0-14 years) living with HIV":"160000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5700","Adults (ages 15+) living with HIV":"150000","Antiretroviral therapy coverage (% of people living with HIV)":"71","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"86","Children (0-14) living with HIV":"8300","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"72000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.78","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.12","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.45","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.79","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.86","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.72","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.25","Incidence of HIV, all (per 1,000 uninfected population)":"0.52","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.9","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"58","Young people (ages 15-24) newly infected with HIV":"1700"},

"Honduras":{"Title":"Honduras","Country Id":"HND","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"25000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1100","Adults (ages 15+) living with HIV":"24000","Antiretroviral therapy coverage (% of people living with HIV)":"48","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"57","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"23000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.08","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.11","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.26","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.11","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"39.1","Young people (ages 15-24) newly infected with HIV":"200"},

"Hong Kong SAR, China":{"Title":"Hong Kong SAR, China","Country Id":"HKG","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Hungary":{"Title":"Hungary","Country Id":"HUN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Iceland":{"Title":"Iceland","Country Id":"ISL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"India":{"Title":"India","Country Id":"IND","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"21.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"31.5","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"20.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"32","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Indonesia":{"Title":"Indonesia","Country Id":"IDN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Iran, Islamic Rep.":{"Title":"Iran, Islamic Rep.","Country Id":"IRN","Adults (ages 15-49) newly infected with HIV":"3700","Adults (ages 15+) and children (0-14 years) living with HIV":"59000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4100","Adults (ages 15+) living with HIV":"58000","Antiretroviral therapy coverage (% of people living with HIV)":"25","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"82","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"23000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.12","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"26.5","Young people (ages 15-24) newly infected with HIV":"1000"},

"Iraq":{"Title":"Iraq","Country Id":"IRQ","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"5.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Ireland":{"Title":"Ireland","Country Id":"IRL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"7500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"7500","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"29.4","Young people (ages 15-24) newly infected with HIV":""},

"Isle of Man":{"Title":"Isle of Man","Country Id":"IMN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Israel":{"Title":"Israel","Country Id":"ISR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Italy":{"Title":"Italy","Country Id":"ITA","Adults (ages 15-49) newly infected with HIV":"2200","Adults (ages 15+) and children (0-14 years) living with HIV":"130000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2500","Adults (ages 15+) living with HIV":"130000","Antiretroviral therapy coverage (% of people living with HIV)":"90","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"4100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"29.4","Young people (ages 15-24) newly infected with HIV":"500"},

"Jamaica":{"Title":"Jamaica","Country Id":"JAM","Adults (ages 15-49) newly infected with HIV":"1500","Adults (ages 15+) and children (0-14 years) living with HIV":"32000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1600","Adults (ages 15+) living with HIV":"32000","Antiretroviral therapy coverage (% of people living with HIV)":"44","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"74","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"14000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.62","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.39","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.84","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.91","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.5","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.32","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.21","Incidence of HIV, all (per 1,000 uninfected population)":"0.57","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"36.4","Young people (ages 15-24) newly infected with HIV":"500"},

"Japan":{"Title":"Japan","Country Id":"JPN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Jordan":{"Title":"Jordan","Country Id":"JOR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"6.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"8.1","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Kazakhstan":{"Title":"Kazakhstan","Country Id":"KAZ","Adults (ages 15-49) newly infected with HIV":"3300","Adults (ages 15+) and children (0-14 years) living with HIV":"33000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"3700","Adults (ages 15+) living with HIV":"33000","Antiretroviral therapy coverage (% of people living with HIV)":"52","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"99","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"6200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"26.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.24","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.16","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.31","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.36","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.21","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.51","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.08","Incidence of HIV, all (per 1,000 uninfected population)":"0.2","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"32.6","Young people (ages 15-24) newly infected with HIV":"1000"},

"Kenya":{"Title":"Kenya","Country Id":"KEN","Adults (ages 15-49) newly infected with HIV":"33000","Adults (ages 15+) and children (0-14 years) living with HIV":"1500000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"42000","Adults (ages 15+) living with HIV":"1400000","Antiretroviral therapy coverage (% of people living with HIV)":"74","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"94","Children (0-14) living with HIV":"110000","Children (ages 0-14) newly infected with HIV":"6800","Children orphaned by HIV/AIDS":"660000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.57","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"2.27","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.88","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"1.47","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.84","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.11","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.41","Incidence of HIV, all (per 1,000 uninfected population)":"0.92","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"2.4","Prevalence of HIV, male (% ages 15-24)":"1.3","Prevalence of HIV, total (% of population ages 15-49)":"4.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"63.4","Young people (ages 15-24) newly infected with HIV":"14000"},

"Kiribati":{"Title":"Kiribati","Country Id":"KIR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Korea, Dem. Peoples Rep.":{"Title":"Korea, Dem. Peoples Rep.","Country Id":"PRK","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Korea, Rep.":{"Title":"Korea, Rep.","Country Id":"KOR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Kosovo":{"Title":"Kosovo","Country Id":"XKX","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Kuwait":{"Title":"Kuwait","Country Id":"KWT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Kyrgyz Republic":{"Title":"Kyrgyz Republic","Country Id":"KGZ","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"10000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"9700","Antiretroviral therapy coverage (% of people living with HIV)":"40","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"78","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"2500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.17","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.11","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.22","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.25","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.15","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.35","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"33.8","Young people (ages 15-24) newly infected with HIV":"200"},

"Lao PDR":{"Title":"Lao PDR","Country Id":"LAO","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"13000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"13000","Antiretroviral therapy coverage (% of people living with HIV)":"56","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"41","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"5900","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"19.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"22.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.23","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.19","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.28","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.15","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.22","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.11","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"43.9","Young people (ages 15-24) newly infected with HIV":"500"},

"Latvia":{"Title":"Latvia","Country Id":"LVA","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"5600","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"5600","Antiretroviral therapy coverage (% of people living with HIV)":"90","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.14","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.14","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.14","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.38","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.22","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.53","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.19","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31.3","Young people (ages 15-24) newly infected with HIV":"100"},

"Lebanon":{"Title":"Lebanon","Country Id":"LBN","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"2700","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"2700","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.09","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"14.6","Young people (ages 15-24) newly infected with HIV":"100"},

"Lesotho":{"Title":"Lesotho","Country Id":"LSO","Adults (ages 15-49) newly infected with HIV":"9500","Adults (ages 15+) and children (0-14 years) living with HIV":"340000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"11000","Adults (ages 15+) living with HIV":"330000","Antiretroviral therapy coverage (% of people living with HIV)":"65","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"84","Children (0-14) living with HIV":"12000","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"85000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"9.99","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"14.71","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"5.61","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"11.35","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"13.86","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"9.23","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.77","Incidence of HIV, all (per 1,000 uninfected population)":"6.43","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"10.1","Prevalence of HIV, male (% ages 15-24)":"4.5","Prevalence of HIV, total (% of population ages 15-49)":"22.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"58.8","Young people (ages 15-24) newly infected with HIV":"3700"},

"Liberia":{"Title":"Liberia","Country Id":"LBR","Adults (ages 15-49) newly infected with HIV":"1700","Adults (ages 15+) and children (0-14 years) living with HIV":"47000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2200","Adults (ages 15+) living with HIV":"43000","Antiretroviral therapy coverage (% of people living with HIV)":"33","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"90","Children (0-14) living with HIV":"3600","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"48000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.9","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.18","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.62","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.74","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.84","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.65","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.37","Incidence of HIV, all (per 1,000 uninfected population)":"0.46","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1","Prevalence of HIV, male (% ages 15-24)":"0.6","Prevalence of HIV, total (% of population ages 15-49)":"1.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.4","Young people (ages 15-24) newly infected with HIV":"1000"},

"Libya":{"Title":"Libya","Country Id":"LBY","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"9500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"9200","Antiretroviral therapy coverage (% of people living with HIV)":"34","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"69","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.09","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.14","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.03","Incidence of HIV, all (per 1,000 uninfected population)":"0.07","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30.1","Young people (ages 15-24) newly infected with HIV":"100"},

"Liechtenstein":{"Title":"Liechtenstein","Country Id":"LIE","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Lithuania":{"Title":"Lithuania","Country Id":"LTU","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"3400","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"3400","Antiretroviral therapy coverage (% of people living with HIV)":"90","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.09","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.19","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.3","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.09","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"25.2","Young people (ages 15-24) newly infected with HIV":"100"},

"Luxembourg":{"Title":"Luxembourg","Country Id":"LUX","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Macao SAR, China":{"Title":"Macao SAR, China","Country Id":"MAC","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Macedonia, FYR":{"Title":"Macedonia, FYR","Country Id":"MKD","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Madagascar":{"Title":"Madagascar","Country Id":"MDG","Adults (ages 15-49) newly infected with HIV":"5200","Adults (ages 15+) and children (0-14 years) living with HIV":"39000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5900","Adults (ages 15+) living with HIV":"37000","Antiretroviral therapy coverage (% of people living with HIV)":"13","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"24","Children (0-14) living with HIV":"1700","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"12000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.19","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.24","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.14","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.4","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.37","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.44","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.09","Incidence of HIV, all (per 1,000 uninfected population)":"0.23","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"46.6","Young people (ages 15-24) newly infected with HIV":"1000"},

"Malawi":{"Title":"Malawi","Country Id":"MWI","Adults (ages 15-49) newly infected with HIV":"29000","Adults (ages 15+) and children (0-14 years) living with HIV":"1100000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"33000","Adults (ages 15+) living with HIV":"1000000","Antiretroviral therapy coverage (% of people living with HIV)":"79","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"65000","Children (ages 0-14) newly infected with HIV":"2500","Children orphaned by HIV/AIDS":"460000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"41.1","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"44.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"42.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"47.5","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"3.31","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"4.74","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.9","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"3.71","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"4.23","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"3.2","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"1.08","Incidence of HIV, all (per 1,000 uninfected population)":"1.94","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"4.2","Prevalence of HIV, male (% ages 15-24)":"2.1","Prevalence of HIV, total (% of population ages 15-49)":"8.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.9","Young people (ages 15-24) newly infected with HIV":"12000"},

"Malaysia":{"Title":"Malaysia","Country Id":"MYS","Adults (ages 15-49) newly infected with HIV":"6100","Adults (ages 15+) and children (0-14 years) living with HIV":"88000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"6300","Adults (ages 15+) living with HIV":"87000","Antiretroviral therapy coverage (% of people living with HIV)":"50","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"42000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.34","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.61","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.34","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.61","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.03","Incidence of HIV, all (per 1,000 uninfected population)":"0.2","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"17.3","Young people (ages 15-24) newly infected with HIV":"1900"},

"Maldives":{"Title":"Maldives","Country Id":"MDV","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"29.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"26.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Mali":{"Title":"Mali","Country Id":"MLI","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"140000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"130000","Antiretroviral therapy coverage (% of people living with HIV)":"36","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"21","Children (0-14) living with HIV":"16000","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"110000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"20.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"28.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.8","Prevalence of HIV, male (% ages 15-24)":"0.4","Prevalence of HIV, total (% of population ages 15-49)":"1.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"63.6","Young people (ages 15-24) newly infected with HIV":""},

"Malta":{"Title":"Malta","Country Id":"MLT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Marshall Islands":{"Title":"Marshall Islands","Country Id":"MHL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Mauritania":{"Title":"Mauritania","Country Id":"MRT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"5700","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"5300","Antiretroviral therapy coverage (% of people living with HIV)":"57","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"63","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"7200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"8.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"8.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"50.6","Young people (ages 15-24) newly infected with HIV":""},

"Mauritius":{"Title":"Mauritius","Country Id":"MUS","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"11000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"11000","Antiretroviral therapy coverage (% of people living with HIV)":"25","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.66","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.45","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.87","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.96","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.57","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"1.35","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.22","Incidence of HIV, all (per 1,000 uninfected population)":"0.57","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.2","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"1.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30.4","Young people (ages 15-24) newly infected with HIV":"200"},

"Mexico":{"Title":"Mexico","Country Id":"MEX","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"31.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Micronesia, Fed. Sts.":{"Title":"Micronesia, Fed. Sts.","Country Id":"FSM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Moldova":{"Title":"Moldova","Country Id":"MDA","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"15000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"14000","Antiretroviral therapy coverage (% of people living with HIV)":"46","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"93","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"3400","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.3","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.21","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.37","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.45","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.29","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.6","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.08","Incidence of HIV, all (per 1,000 uninfected population)":"0.23","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"37.7","Young people (ages 15-24) newly infected with HIV":"100"},

"Monaco":{"Title":"Monaco","Country Id":"MCO","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Mongolia":{"Title":"Mongolia","Country Id":"MNG","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"1000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"1000","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.02","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.02","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.03","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.01","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"18.9","Young people (ages 15-24) newly infected with HIV":"100"},

"Montenegro":{"Title":"Montenegro","Country Id":"MNE","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"500","Antiretroviral therapy coverage (% of people living with HIV)":"40","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.02","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.18","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"12","Young people (ages 15-24) newly infected with HIV":"100"},

"Morocco":{"Title":"Morocco","Country Id":"MAR","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"21000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"21000","Antiretroviral therapy coverage (% of people living with HIV)":"70","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"73","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"7100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.03","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.05","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.02","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"42.6","Young people (ages 15-24) newly infected with HIV":"500"},

"Mozambique":{"Title":"Mozambique","Country Id":"MOZ","Adults (ages 15-49) newly infected with HIV":"110000","Adults (ages 15+) and children (0-14 years) living with HIV":"2200000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"130000","Adults (ages 15+) living with HIV":"2100000","Antiretroviral therapy coverage (% of people living with HIV)":"60","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"150000","Children (ages 0-14) newly infected with HIV":"15000","Children orphaned by HIV/AIDS":"1100000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"30.8","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"30.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"8.73","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"12.17","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"5.48","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"8.94","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"10.53","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"7.39","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.63","Incidence of HIV, all (per 1,000 uninfected population)":"4.68","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"7.1","Prevalence of HIV, male (% ages 15-24)":"2.8","Prevalence of HIV, total (% of population ages 15-49)":"12.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61.9","Young people (ages 15-24) newly infected with HIV":"53000"},

"Myanmar":{"Title":"Myanmar","Country Id":"MMR","Adults (ages 15-49) newly infected with HIV":"9100","Adults (ages 15+) and children (0-14 years) living with HIV":"240000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"10000","Adults (ages 15+) living with HIV":"230000","Antiretroviral therapy coverage (% of people living with HIV)":"76","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"85","Children (0-14) living with HIV":"11000","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"120000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"16.2","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"17.8","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"19.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"22.3","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.56","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.45","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.67","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.31","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.21","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.42","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.19","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"0.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"38.4","Young people (ages 15-24) newly infected with HIV":"5500"},

"Namibia":{"Title":"Namibia","Country Id":"NAM","Adults (ages 15-49) newly infected with HIV":"5900","Adults (ages 15+) and children (0-14 years) living with HIV":"210000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"6900","Adults (ages 15+) living with HIV":"200000","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"10000","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"37000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"4.4","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"6.18","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"2.62","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"5.34","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"6.64","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"4.08","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"2.41","Incidence of HIV, all (per 1,000 uninfected population)":"3.1","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"4.8","Prevalence of HIV, male (% ages 15-24)":"2.7","Prevalence of HIV, total (% of population ages 15-49)":"11.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"63.4","Young people (ages 15-24) newly infected with HIV":"2000"},

"Nauru":{"Title":"Nauru","Country Id":"NRU","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Nepal":{"Title":"Nepal","Country Id":"NPL","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"30000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"28000","Antiretroviral therapy coverage (% of people living with HIV)":"63","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"51","Children (0-14) living with HIV":"1200","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"21000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.02","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.03","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.07","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"40","Young people (ages 15-24) newly infected with HIV":"200"},

"Netherlands":{"Title":"Netherlands","Country Id":"NLD","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"24000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"23000","Antiretroviral therapy coverage (% of people living with HIV)":"87","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"80","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.06","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.02","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"17.4","Young people (ages 15-24) newly infected with HIV":"100"},

"New Caledonia":{"Title":"New Caledonia","Country Id":"NCL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"New Zealand":{"Title":"New Zealand","Country Id":"NZL","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"3500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"3500","Antiretroviral therapy coverage (% of people living with HIV)":"63","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.11","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"16.4","Young people (ages 15-24) newly infected with HIV":"100"},

"Nicaragua":{"Title":"Nicaragua","Country Id":"NIC","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"9600","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"9400","Antiretroviral therapy coverage (% of people living with HIV)":"59","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"98","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"4300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.09","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.1","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.15","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"33.1","Young people (ages 15-24) newly infected with HIV":"100"},

"Niger":{"Title":"Niger","Country Id":"NER","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"33000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1300","Adults (ages 15+) living with HIV":"30000","Antiretroviral therapy coverage (% of people living with HIV)":"61","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"43","Children (0-14) living with HIV":"3000","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"47000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.09","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"57.4","Young people (ages 15-24) newly infected with HIV":"200"},

"Nigeria":{"Title":"Nigeria","Country Id":"NGA","Adults (ages 15-49) newly infected with HIV":"76000","Adults (ages 15+) and children (0-14 years) living with HIV":"1800000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100000","Adults (ages 15+) living with HIV":"1600000","Antiretroviral therapy coverage (% of people living with HIV)":"65","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"43","Children (0-14) living with HIV":"150000","Children (ages 0-14) newly infected with HIV":"22000","Children orphaned by HIV/AIDS":"740000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"29.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"27.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.71","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.94","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.5","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.78","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.91","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.66","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.28","Incidence of HIV, all (per 1,000 uninfected population)":"0.52","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.6","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"1.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"58.5","Young people (ages 15-24) newly infected with HIV":"28000"},

"Northern Mariana Islands":{"Title":"Northern Mariana Islands","Country Id":"MNP","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Norway":{"Title":"Norway","Country Id":"NOR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Oman":{"Title":"Oman","Country Id":"OMN","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"2500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"2400","Antiretroviral therapy coverage (% of people living with HIV)":"70","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.07","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.1","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31","Young people (ages 15-24) newly infected with HIV":"100"},

"Pakistan":{"Title":"Pakistan","Country Id":"PAK","Adults (ages 15-49) newly infected with HIV":"22000","Adults (ages 15+) and children (0-14 years) living with HIV":"190000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"25000","Adults (ages 15+) living with HIV":"180000","Antiretroviral therapy coverage (% of people living with HIV)":"12","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"12","Children (0-14) living with HIV":"6100","Children (ages 0-14) newly infected with HIV":"1500","Children orphaned by HIV/AIDS":"53000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.18","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.2","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.28","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.12","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"29.7","Young people (ages 15-24) newly infected with HIV":"5600"},

"Palau":{"Title":"Palau","Country Id":"PLW","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Panama":{"Title":"Panama","Country Id":"PAN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Papua New Guinea":{"Title":"Papua New Guinea","Country Id":"PNG","Adults (ages 15-49) newly infected with HIV":"2700","Adults (ages 15+) and children (0-14 years) living with HIV":"52000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"3300","Adults (ages 15+) living with HIV":"48000","Antiretroviral therapy coverage (% of people living with HIV)":"62","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"81","Children (0-14) living with HIV":"3200","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"9000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.52","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.68","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.36","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.61","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.71","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.52","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.22","Incidence of HIV, all (per 1,000 uninfected population)":"0.38","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.9","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"57.3","Young people (ages 15-24) newly infected with HIV":"1000"},

"Paraguay":{"Title":"Paraguay","Country Id":"PRY","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"22000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1100","Adults (ages 15+) living with HIV":"21000","Antiretroviral therapy coverage (% of people living with HIV)":"44","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"94","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"15000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"27.5","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.3","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.22","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.38","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.28","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.16","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.39","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.16","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31","Young people (ages 15-24) newly infected with HIV":"500"},

"Peru":{"Title":"Peru","Country Id":"PER","Adults (ages 15-49) newly infected with HIV":"3000","Adults (ages 15+) and children (0-14 years) living with HIV":"87000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"3300","Adults (ages 15+) living with HIV":"85000","Antiretroviral therapy coverage (% of people living with HIV)":"77","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"82","Children (0-14) living with HIV":"1400","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"21000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.18","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.07","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.28","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.03","Incidence of HIV, all (per 1,000 uninfected population)":"0.1","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"23.7","Young people (ages 15-24) newly infected with HIV":"500"},

"Philippines":{"Title":"Philippines","Country Id":"PHL","Adults (ages 15-49) newly infected with HIV":"15000","Adults (ages 15+) and children (0-14 years) living with HIV":"97000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"16000","Adults (ages 15+) living with HIV":"96000","Antiretroviral therapy coverage (% of people living with HIV)":"44","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"25","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"11000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.36","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.66","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.27","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.5","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.14","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"6","Young people (ages 15-24) newly infected with HIV":"7300"},

"Poland":{"Title":"Poland","Country Id":"POL","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Portugal":{"Title":"Portugal","Country Id":"PRT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Puerto Rico":{"Title":"Puerto Rico","Country Id":"PRI","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Qatar":{"Title":"Qatar","Country Id":"QAT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Romania":{"Title":"Romania","Country Id":"ROU","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"19000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"19000","Antiretroviral therapy coverage (% of people living with HIV)":"68","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.12","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"40","Young people (ages 15-24) newly infected with HIV":"100"},

"Russian Federation":{"Title":"Russian Federation","Country Id":"RUS","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Rwanda":{"Title":"Rwanda","Country Id":"RWA","Adults (ages 15-49) newly infected with HIV":"4500","Adults (ages 15+) and children (0-14 years) living with HIV":"230000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5300","Adults (ages 15+) living with HIV":"220000","Antiretroviral therapy coverage (% of people living with HIV)":"87","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"99","Children (0-14) living with HIV":"14000","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"70000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"64.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"64.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"66.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"68.8","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.67","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.99","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.36","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.76","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.88","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.63","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.25","Incidence of HIV, all (per 1,000 uninfected population)":"0.44","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.1","Prevalence of HIV, male (% ages 15-24)":"0.7","Prevalence of HIV, total (% of population ages 15-49)":"2.6","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61.2","Young people (ages 15-24) newly infected with HIV":"1500"},

"Samoa":{"Title":"Samoa","Country Id":"WSM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"San Marino":{"Title":"San Marino","Country Id":"SMR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Sao Tome and Principe":{"Title":"Sao Tome and Principe","Country Id":"STP","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Saudi Arabia":{"Title":"Saudi Arabia","Country Id":"SAU","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Senegal":{"Title":"Senegal","Country Id":"SEN","Adults (ages 15-49) newly infected with HIV":"1100","Adults (ages 15+) and children (0-14 years) living with HIV":"41000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1400","Adults (ages 15+) living with HIV":"38000","Antiretroviral therapy coverage (% of people living with HIV)":"70","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"72","Children (0-14) living with HIV":"3800","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"38000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"25.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"32.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.14","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.13","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.16","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.03","Incidence of HIV, all (per 1,000 uninfected population)":"0.09","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"58.3","Young people (ages 15-24) newly infected with HIV":"500"},

"Serbia":{"Title":"Serbia","Country Id":"SRB","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"3200","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"3200","Antiretroviral therapy coverage (% of people living with HIV)":"68","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.02","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.08","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.02","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"15.4","Young people (ages 15-24) newly infected with HIV":"100"},

"Seychelles":{"Title":"Seychelles","Country Id":"SYC","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Sierra Leone":{"Title":"Sierra Leone","Country Id":"SLE","Adults (ages 15-49) newly infected with HIV":"3400","Adults (ages 15+) and children (0-14 years) living with HIV":"78000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4900","Adults (ages 15+) living with HIV":"69000","Antiretroviral therapy coverage (% of people living with HIV)":"43","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"58","Children (0-14) living with HIV":"9100","Children (ages 0-14) newly infected with HIV":"1300","Children orphaned by HIV/AIDS":"41000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"26.7","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"30.9","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"1.19","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.56","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.83","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.92","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.79","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.29","Incidence of HIV, all (per 1,000 uninfected population)":"0.65","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.2","Prevalence of HIV, male (% ages 15-24)":"0.6","Prevalence of HIV, total (% of population ages 15-49)":"1.6","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"60.2","Young people (ages 15-24) newly infected with HIV":"1800"},

"Singapore":{"Title":"Singapore","Country Id":"SGP","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"7900","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"7900","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"1000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.05","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.07","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"9.4","Young people (ages 15-24) newly infected with HIV":"100"},

"Sint Maarten (Dutch part)":{"Title":"Sint Maarten (Dutch part)","Country Id":"SXM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Slovak Republic":{"Title":"Slovak Republic","Country Id":"SVK","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Slovenia":{"Title":"Slovenia","Country Id":"SVN","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Solomon Islands":{"Title":"Solomon Islands","Country Id":"SLB","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Somalia":{"Title":"Somalia","Country Id":"SOM","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"11000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"9500","Antiretroviral therapy coverage (% of people living with HIV)":"33","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"24","Children (0-14) living with HIV":"1100","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"18000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.02","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.04","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.03","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"54","Young people (ages 15-24) newly infected with HIV":"100"},

"South Africa":{"Title":"South Africa","Country Id":"ZAF","Adults (ages 15-49) newly infected with HIV":"170000","Adults (ages 15+) and children (0-14 years) living with HIV":"7500000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200000","Adults (ages 15+) living with HIV":"7200000","Antiretroviral therapy coverage (% of people living with HIV)":"70","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"97","Children (0-14) living with HIV":"340000","Children (ages 0-14) newly infected with HIV":"10000","Children orphaned by HIV/AIDS":"1400000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"40.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"39.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"7.93","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"12.98","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"3.29","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"6.9","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"9.63","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"4.52","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"1.72","Incidence of HIV, all (per 1,000 uninfected population)":"3.98","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"10.2","Prevalence of HIV, male (% ages 15-24)":"3.4","Prevalence of HIV, total (% of population ages 15-49)":"19","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"65.2","Young people (ages 15-24) newly infected with HIV":"70000"},

"South Sudan":{"Title":"South Sudan","Country Id":"SSD","Adults (ages 15-49) newly infected with HIV":"15000","Adults (ages 15+) and children (0-14 years) living with HIV":"190000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"19000","Adults (ages 15+) living with HIV":"180000","Antiretroviral therapy coverage (% of people living with HIV)":"18","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"44","Children (0-14) living with HIV":"16000","Children (ages 0-14) newly infected with HIV":"2700","Children orphaned by HIV/AIDS":"120000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"2.1","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"2.73","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.49","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"2.53","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"2.93","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"2.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.85","Incidence of HIV, all (per 1,000 uninfected population)":"1.5","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1.3","Prevalence of HIV, male (% ages 15-24)":"0.7","Prevalence of HIV, total (% of population ages 15-49)":"2.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"58.9","Young people (ages 15-24) newly infected with HIV":"5300"},

"Spain":{"Title":"Spain","Country Id":"ESP","Adults (ages 15-49) newly infected with HIV":"2500","Adults (ages 15+) and children (0-14 years) living with HIV":"150000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"2700","Adults (ages 15+) living with HIV":"150000","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"6200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.13","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.03","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.23","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.03","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.21","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.06","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"18.4","Young people (ages 15-24) newly infected with HIV":"1000"},

"Sri Lanka":{"Title":"Sri Lanka","Country Id":"LKA","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"3600","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"3600","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"2200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.01","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.02","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.01","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"28.5","Young people (ages 15-24) newly infected with HIV":"100"},

"St. Kitts and Nevis":{"Title":"St. Kitts and Nevis","Country Id":"KNA","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"St. Lucia":{"Title":"St. Lucia","Country Id":"LCA","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"St. Martin (French part)":{"Title":"St. Martin (French part)","Country Id":"MAF","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"St. Vincent and the Grenadines":{"Title":"St. Vincent and the Grenadines","Country Id":"VCT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Sudan":{"Title":"Sudan","Country Id":"SDN","Adults (ages 15-49) newly infected with HIV":"2700","Adults (ages 15+) and children (0-14 years) living with HIV":"46000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"3500","Adults (ages 15+) living with HIV":"42000","Antiretroviral therapy coverage (% of people living with HIV)":"22","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"4","Children (0-14) living with HIV":"4000","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"40000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.1","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.09","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.13","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.15","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.04","Incidence of HIV, all (per 1,000 uninfected population)":"0.08","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"48.4","Young people (ages 15-24) newly infected with HIV":"1000"},

"Suriname":{"Title":"Suriname","Country Id":"SUR","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"5800","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"5600","Antiretroviral therapy coverage (% of people living with HIV)":"50","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"74","Children (0-14) living with HIV":"200","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"2100","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.35","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.43","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.27","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.75","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.63","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.87","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.16","Incidence of HIV, all (per 1,000 uninfected population)":"0.45","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"1.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"45","Young people (ages 15-24) newly infected with HIV":"100"},

"Sweden":{"Title":"Sweden","Country Id":"SWE","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Switzerland":{"Title":"Switzerland","Country Id":"CHE","Adults (ages 15-49) newly infected with HIV":"500","Adults (ages 15+) and children (0-14 years) living with HIV":"17000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"500","Adults (ages 15+) living with HIV":"17000","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"17000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"0.03","New HIV infections (per 1000 uninfected population) Both Sex":"0.03","Number of deaths due to HIV/AIDS":"100","Number of new HIV infections":"500","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Syrian Arab Republic":{"Title":"Syrian Arab Republic","Country Id":"SYR","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"1000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"100","Adults (ages 15+) living with HIV":"1000","Antiretroviral therapy coverage (% of people living with HIV)":"22","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.01","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.01","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.01","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.01","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.01","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"30.8","Young people (ages 15-24) newly infected with HIV":"100"},

"Tajikistan":{"Title":"Tajikistan","Country Id":"TJK","Adults (ages 15-49) newly infected with HIV":"1100","Adults (ages 15+) and children (0-14 years) living with HIV":"14000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1600","Adults (ages 15+) living with HIV":"13000","Antiretroviral therapy coverage (% of people living with HIV)":"51","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"88","Children (0-14) living with HIV":"1000","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"3200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.16","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.23","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.25","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.38","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.17","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"25.6","Young people (ages 15-24) newly infected with HIV":"500"},

"Tanzania":{"Title":"Tanzania","Country Id":"TZA","Adults (ages 15-49) newly infected with HIV":"63000","Adults (ages 15+) and children (0-14 years) living with HIV":"1700000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"77000","Adults (ages 15+) living with HIV":"1600000","Antiretroviral therapy coverage (% of people living with HIV)":"75","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"92","Children (0-14) living with HIV":"93000","Children (ages 0-14) newly infected with HIV":"8600","Children orphaned by HIV/AIDS":"860000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"2.3","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"3.19","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.42","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"2.57","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"3.07","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"2.08","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"1.3","Incidence of HIV, all (per 1,000 uninfected population)":"1.46","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"2.2","Prevalence of HIV, male (% ages 15-24)":"1.2","Prevalence of HIV, total (% of population ages 15-49)":"4.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61","Young people (ages 15-24) newly infected with HIV":"24000"},

"Thailand":{"Title":"Thailand","Country Id":"THA","Adults (ages 15-49) newly infected with HIV":"5300","Adults (ages 15+) and children (0-14 years) living with HIV":"470000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5400","Adults (ages 15+) living with HIV":"470000","Antiretroviral therapy coverage (% of people living with HIV)":"80","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"97","Children (0-14) living with HIV":"3300","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"230000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"46","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"45.1","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.29","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.16","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.41","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.15","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.22","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.08","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.2","Prevalence of HIV, male (% ages 15-24)":"0.3","Prevalence of HIV, total (% of population ages 15-49)":"1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"44.2","Young people (ages 15-24) newly infected with HIV":"2700"},

"Timor-Leste":{"Title":"Timor-Leste","Country Id":"TLS","Adults (ages 15-49) newly infected with HIV":"200","Adults (ages 15+) and children (0-14 years) living with HIV":"1500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"1400","Antiretroviral therapy coverage (% of people living with HIV)":"80","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"500","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.12","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.17","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.26","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.26","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.26","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.06","Incidence of HIV, all (per 1,000 uninfected population)":"0.15","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"45.2","Young people (ages 15-24) newly infected with HIV":"100"},

"Togo":{"Title":"Togo","Country Id":"TGO","Adults (ages 15-49) newly infected with HIV":"3300","Adults (ages 15+) and children (0-14 years) living with HIV":"120000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4500","Adults (ages 15+) living with HIV":"110000","Antiretroviral therapy coverage (% of people living with HIV)":"64","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"76","Children (0-14) living with HIV":"9900","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"78000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.81","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"1.22","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.41","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.9","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"1.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.73","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.3","Incidence of HIV, all (per 1,000 uninfected population)":"0.59","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"1","Prevalence of HIV, male (% ages 15-24)":"0.5","Prevalence of HIV, total (% of population ages 15-49)":"2.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"62.9","Young people (ages 15-24) newly infected with HIV":"1200"},

"Tonga":{"Title":"Tonga","Country Id":"TON","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Trinidad and Tobago":{"Title":"Trinidad and Tobago","Country Id":"TTO","Adults (ages 15-49) newly infected with HIV":"100","Adults (ages 15+) and children (0-14 years) living with HIV":"11000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"200","Adults (ages 15+) living with HIV":"10000","Antiretroviral therapy coverage (% of people living with HIV)":"50","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"2300","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.05","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.07","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.11","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.14","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.07","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.7","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"51","Young people (ages 15-24) newly infected with HIV":"100"},

"Tunisia":{"Title":"Tunisia","Country Id":"TUN","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"6500","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"6400","Antiretroviral therapy coverage (% of people living with HIV)":"20","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"32","Children (0-14) living with HIV":"100","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"1700","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.04","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.06","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.13","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"25.8","Young people (ages 15-24) newly infected with HIV":"100"},

"Turkey":{"Title":"Turkey","Country Id":"TUR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Turkmenistan":{"Title":"Turkmenistan","Country Id":"TKM","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"88","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"25.4","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Turks and Caicos Islands":{"Title":"Turks and Caicos Islands","Country Id":"TCA","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Tuvalu":{"Title":"Tuvalu","Country Id":"TUV","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Uganda":{"Title":"Uganda","Country Id":"UGA","Adults (ages 15-49) newly infected with HIV":"45000","Adults (ages 15+) and children (0-14 years) living with HIV":"1500000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"53000","Adults (ages 15+) living with HIV":"1400000","Antiretroviral therapy coverage (% of people living with HIV)":"84","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"100","Children (0-14) living with HIV":"100000","Children (ages 0-14) newly infected with HIV":"5700","Children orphaned by HIV/AIDS":"880000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"2.4","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"3.52","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"1.28","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"2.61","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"3.03","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"2.18","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.9","Incidence of HIV, all (per 1,000 uninfected population)":"1.38","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"2.8","Prevalence of HIV, male (% ages 15-24)":"1.2","Prevalence of HIV, total (% of population ages 15-49)":"5.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"61.2","Young people (ages 15-24) newly infected with HIV":"20000"},

"Ukraine":{"Title":"Ukraine","Country Id":"UKR","Adults (ages 15-49) newly infected with HIV":"12000","Adults (ages 15+) and children (0-14 years) living with HIV":"250000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"13000","Adults (ages 15+) living with HIV":"250000","Antiretroviral therapy coverage (% of people living with HIV)":"54","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"92","Children (0-14) living with HIV":"2900","Children (ages 0-14) newly infected with HIV":"200","Children orphaned by HIV/AIDS":"64000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.31","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.27","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.34","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.56","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.42","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.7","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.28","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"44.5","Young people (ages 15-24) newly infected with HIV":"1300"},

"United Arab Emirates":{"Title":"United Arab Emirates","Country Id":"ARE","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"United Kingdom":{"Title":"United Kingdom","Country Id":"GBR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"United States":{"Title":"United States","Country Id":"USA","Adults (ages 15-49) newly infected with HIV":"33000","Adults (ages 15+) and children (0-14 years) living with HIV":"1200000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"37000","Adults (ages 15+) living with HIV":"1200000","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"95000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"1200000","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.08","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.11","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.22","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.08","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.36","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.03","Incidence of HIV, all (per 1,000 uninfected population)":"0.11","New HIV infections (per 1000 uninfected population) Both Sex":"0.11","Number of deaths due to HIV/AIDS":"7800","Number of new HIV infections":"37000","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.4","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"21.5","Young people (ages 15-24) newly infected with HIV":"3400"},

"Uruguay":{"Title":"Uruguay","Country Id":"URY","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Uzbekistan":{"Title":"Uzbekistan","Country Id":"UZB","Adults (ages 15-49) newly infected with HIV":"3300","Adults (ages 15+) and children (0-14 years) living with HIV":"50000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"4400","Adults (ages 15+) living with HIV":"44000","Antiretroviral therapy coverage (% of people living with HIV)":"58","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"75","Children (0-14) living with HIV":"5900","Children (ages 0-14) newly infected with HIV":"1000","Children orphaned by HIV/AIDS":"9200","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.12","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.09","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.15","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.18","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.24","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.05","Incidence of HIV, all (per 1,000 uninfected population)":"0.13","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.2","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"37.1","Young people (ages 15-24) newly infected with HIV":"1000"},

"Vanuatu":{"Title":"Vanuatu","Country Id":"VUT","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Venezuela":{"Title":"Venezuela","Country Id":"VEN","Adults (ages 15-49) newly infected with HIV":"4600","Adults (ages 15+) and children (0-14 years) living with HIV":"110000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5200","Adults (ages 15+) living with HIV":"110000","Antiretroviral therapy coverage (% of people living with HIV)":"40","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"17","Children (0-14) living with HIV":"3900","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"30000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.4","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.43","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.37","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.33","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.3","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.36","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.19","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.3","Prevalence of HIV, male (% ages 15-24)":"0.2","Prevalence of HIV, total (% of population ages 15-49)":"0.6","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"41.3","Young people (ages 15-24) newly infected with HIV":"1900"},

"Vietnam":{"Title":"Vietnam","Country Id":"VNM","Adults (ages 15-49) newly infected with HIV":"4400","Adults (ages 15+) and children (0-14 years) living with HIV":"230000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"5200","Adults (ages 15+) living with HIV":"220000","Antiretroviral therapy coverage (% of people living with HIV)":"70","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"86","Children (0-14) living with HIV":"5200","Children (ages 0-14) newly infected with HIV":"500","Children orphaned by HIV/AIDS":"92000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.04","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.08","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.09","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.05","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.12","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.02","Incidence of HIV, all (per 1,000 uninfected population)":"0.05","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.3","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"31.3","Young people (ages 15-24) newly infected with HIV":"1000"},

"Virgin Islands (U.S.)":{"Title":"Virgin Islands (U.S.)","Country Id":"VIR","Adults (ages 15-49) newly infected with HIV":"","Adults (ages 15+) and children (0-14 years) living with HIV":"","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"","Adults (ages 15+) living with HIV":"","Antiretroviral therapy coverage (% of people living with HIV)":"","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"","Children (0-14) living with HIV":"","Children (ages 0-14) newly infected with HIV":"","Children orphaned by HIV/AIDS":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"","Incidence of HIV, all (per 1,000 uninfected population)":"","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"","Prevalence of HIV, male (% ages 15-24)":"","Prevalence of HIV, total (% of population ages 15-49)":"","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"","Young people (ages 15-24) newly infected with HIV":""},

"Yemen, Rep.":{"Title":"Yemen, Rep.","Country Id":"YEM","Adults (ages 15-49) newly infected with HIV":"1000","Adults (ages 15+) and children (0-14 years) living with HIV":"11000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"1000","Adults (ages 15+) living with HIV":"11000","Antiretroviral therapy coverage (% of people living with HIV)":"24","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"40","Children (0-14) living with HIV":"500","Children (ages 0-14) newly infected with HIV":"100","Children orphaned by HIV/AIDS":"6700","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"0.02","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"0.03","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"0.07","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"0.02","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"0.11","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"0.01","Incidence of HIV, all (per 1,000 uninfected population)":"0.04","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"0.1","Prevalence of HIV, male (% ages 15-24)":"0.1","Prevalence of HIV, total (% of population ages 15-49)":"0.1","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"21.9","Young people (ages 15-24) newly infected with HIV":"200"},

"Zambia":{"Title":"Zambia","Country Id":"ZMB","Adults (ages 15-49) newly infected with HIV":"43000","Adults (ages 15+) and children (0-14 years) living with HIV":"1200000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"51000","Adults (ages 15+) living with HIV":"1200000","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"86","Children (0-14) living with HIV":"66000","Children (ages 0-14) newly infected with HIV":"6000","Children orphaned by HIV/AIDS":"350000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"6.06","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"8.39","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"3.73","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"6.03","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"7.12","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"4.95","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"1.89","Incidence of HIV, all (per 1,000 uninfected population)":"3.17","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"5.5","Prevalence of HIV, male (% ages 15-24)":"2.6","Prevalence of HIV, total (% of population ages 15-49)":"11.5","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.8","Young people (ages 15-24) newly infected with HIV":"19000"},

"Zimbabwe":{"Title":"Zimbabwe","Country Id":"ZWE","Adults (ages 15-49) newly infected with HIV":"33000","Adults (ages 15+) and children (0-14 years) living with HIV":"1400000","Adults (ages 15+) and children (ages 0-14) newly infected with HIV":"40000","Adults (ages 15+) living with HIV":"1300000","Antiretroviral therapy coverage (% of people living with HIV)":"85","Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)":"91","Children (0-14) living with HIV":"84000","Children (ages 0-14) newly infected with HIV":"5200","Children orphaned by HIV/AIDS":"500000","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)":"46.3","Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)":"46.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)":"54.6","Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)":"55.9","Estimated antiretroviral therapy coverage among children":"","Estimated number of children needing antiretroviral therapy based on WHO methods":"","Estimated number of people (all ages) living with HIV":"","Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods":"","Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission":"","Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)":"4.82","Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)":"6.68","Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)":"3.01","Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)":"4.87","Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)":"5.64","Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)":"4.12","Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)":"1.29","Incidence of HIV, all (per 1,000 uninfected population)":"2.81","New HIV infections (per 1000 uninfected population) Both Sex":"","Number of deaths due to HIV/AIDS":"","Number of new HIV infections":"","Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine) for preventing mother-to-child transmission":"","Prevalence of HIV, female (% ages 15-24)":"5.9","Prevalence of HIV, male (% ages 15-24)":"3.3","Prevalence of HIV, total (% of population ages 15-49)":"12.8","Reported number of children receiving antiretroviral therapy":"","Reported number of people receiving antiretroviral therapy":"","Women's share of population ages 15+ living with HIV (%)":"59.6","Young people (ages 15-24) newly infected with HIV":"13000"}

}

